Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taizhou Hanzhong Biotechnology is a medical technology firm based in Taizhou, China, specializing in the development and production of in vitro diagnostic (IVD) reagents and instruments. The company primarily utilizes colloidal gold and fluorescence immunochromatography platforms to create rapid testing solutions for a variety of clinical applications. Its product catalog features diagnostic kits for respiratory infections, cardiac markers, tumor markers, and drugs of abuse. Taizhou Hanzhong Biotechnology operates manufacturing facilities compliant with medical device standards to supply point-of-care testing products to global markets. The company's focus on rapid, reliable, and easy-to-use diagnostics supports healthcare providers in diverse settings, from hospitals to remote clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taizhou Hanzhong Biotechnology.